参考文章(9)
MARK J YOUNG, EDDY A BRESNITZ, BRIAN L STROM, Sample Size Nomograms For Interpreting Negative Clinical Studies Annals of Internal Medicine. ,vol. 99, pp. 248- 251 ,(1983) , 10.7326/0003-4819-99-2-248
Jennie A. Freiman, Thomas C. Chalmers, Harry Smith, Roy R. Kuebler, The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. The New England Journal of Medicine. ,vol. 299, pp. 690- 694 ,(1978) , 10.1056/NEJM197809282991304
John M. Lachin, Introduction to sample size determination and power analysis for clinical trials Controlled Clinical Trials. ,vol. 2, pp. 93- 113 ,(1981) , 10.1016/0197-2456(81)90001-5
P Wright, J Haybittle, Design of forms for clinical trials (2). BMJ. ,vol. 2, pp. 590- 592 ,(1979) , 10.1136/BMJ.2.6190.590
Allan Donner, Approaches to sample size estimation in the design of clinical trials—a review Statistics in Medicine. ,vol. 3, pp. 199- 214 ,(1984) , 10.1002/SIM.4780030302
P Wright, J Haybittle, Design of forms for clinical trials (1). BMJ. ,vol. 2, pp. 529- 530 ,(1979) , 10.1136/BMJ.2.6189.529
P Wright, J Haybittle, Design of forms for clinical trials (3). BMJ. ,vol. 2, pp. 650- 651 ,(1979) , 10.1136/BMJ.2.6191.650